Miami, April 6, 2022 – Privately-held company Guard Medical Inc. today announces the completion of a Series B investment of $11 million to support commercialization and clinical studies of its next generation Negative Pressure Wound Therapy (NPWT) dressing NPseal™ for the treatment of closed surgical incisions. NPseal™ is an easy-to-use and cost-effective NPWT surgical dressing with an integrated pump that establishes and maintains negative pressure with just a few pinches.
Press Release
Guard Medical Announces FDA 510k clearance for additional sizes of its novel NPseal, the first all-in-one NPWT surgical dressing
Miami, February 15, 2022 – Privately-held company Guard Medical Inc. today announces FDA 510k clearance for additional sizes (10 and 15cm) of its next generation Negative Pressure Wound Therapy (NPWT) dressing NPseal™ for the treatment of closed surgical incisions. NPseal™ is an easy-to-use and cost-effective NPWT surgical dressing with an integrated pump that establishes and maintains negative pressure with just a few pinches.
Guard Medical announces the successful completion of the first post-market study of its NPseal™
Miami, February 8, 2022 – Privately-held company Guard Medical Inc. today announces the successful completion of the post-market study of its NPseal™ at Keck Medical Center of USC. NPseal™ is the next generation, All-in-One Negative Pressure Wound Therapy (NPWT) system for the treatment of closed surgical incisions. Guard Medical’s simple, innovative and cost-effective NPWT NPseal™ is a wearable dressing with an integrated pump that establishes and maintains negative pressure with just a few pinches.
Guard Medical announces the enrollment of the first 5 patients in the post-market study of its NPseal™
Miami, June 7, 2021 – Privately-held company Guard Medical Inc. today announces enrollment of the first five patients in the post-market study of its NPseal™ at Keck Medical Center of USC. NPseal™ is the next generation, All-in-One Negative Pressure Wound Therapy (NPWT) system for the treatment of closed surgical incisions. Guard Medical’s simple, innovative and cost-effective NPWT NPseal™ is a wearable dressing with an integrated pump that establishes and maintains negative pressure with just a few pinches.
Guard Medical Announces FDA 510k clearance for increased wear time of its novel NPseal™, the first all-in-one NPWT surgical dressing
Miami, May 24, 2021 – Privately-held Guard Medical Inc. today announces FDA 510k clearance of a wear time extension from 3 to 6 days for its next generation Negative Pressure Wound Therapy (NPWT) dressing NPseal™ for the treatment of closed surgical incisions. Guard Medical’s simple, innovative and cost-effective NPWT NPseal™ is a wearable dressing with an integrated pump that establishes and maintains negative pressure with just a few pinches.
Guard Medical reports follow-on $5 million cash infusion following FDA 510k clearance for its novel NPseal™, the first all-in-one NPWT surgical dressing
New York, June 29, 2020 – Privately-held Guard Medical Inc. today announces a substantial cash infusion of $5 million following the achievement of the important milestone of FDA 510k clearance for its next generation Negative Pressure Wound Therapy (NPWT) dressing NPseal™ for the treatment of closed surgical incisions. Guard Medical’s simple, innovative and cost-effective NPWT NPseal™ is a wearable dressing with an integrated pump that establishes and maintains negative pressure with just a few pinches.